Health And Medicine
-
Leader in Vanderbilt drug discovery efforts, Craig Lindsley named interim editor-in-chief of ACS Pharmacology & Translational Science
Craig Lindsley, William K. Warren, Jr. Chair in Medicine and university professor of biochemistry, chemistry and pharmacology, has been named interim editor-in-chief of the journal "ACS Pharmacology & Translational Science." Read MoreJun 12, 2020
-
Robotic technology speeds arrhythmia gene classification
Vanderbilt University Medical Center investigators have used high-throughput robotic technology to rapidly study and classify variations in a gene linked to heart rhythm disorders and cardiac conditions. Read MoreJun 12, 2020
-
Breast cancer vaccine research delivers promising results
Vanderbilt researchers have developed what appears to be a simple and promising treatment for breast cancer metastasis. Read MoreJun 11, 2020
-
C.diff captures blood cell cofactor to build defensive shield
Vanderbilt University Medical Center scientists have identified a C. diff protein system that senses and captures heme (part of hemoglobin) to build a protective shield that fends off threats from our immune system and antibiotics. Read MoreJun 10, 2020
-
Vanderbilt, AstraZeneca sign new COVID-19 antibody agreement
After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio. Read MoreJun 9, 2020
-
Staph’s activation of blood clotting
Staph bacteria may change the factor they use to activate blood clotting — to evade the immune response — a new study suggests. Read MoreJun 9, 2020
-
Vanderbilt researcher finds COVID-19 pandemic shapes opportunities for radical change to the U.S. health care system
A new article from Jonathan Metzl details how COVID-19 has dramatically revealed the ways that institutionalized inequality and structural racism shape health, and provides recommendations for radical change to the U.S. health care system. Read MoreJun 4, 2020
-
Protecting the injured kidney
Leslie Gewin and colleagues have upended conventional dogma about Wnt/beta-catenin signaling in the kidney, finding that it protects against chronic kidney disease rather than promoting it. Read MoreJun 4, 2020
-
Potential new cancer target
Vanderbilt researchers have discovered the involvement of a certain type of adenosine receptor in mediating signaling that supports tumor growth and metastasis. Read MoreJun 4, 2020
-
Remdesivir helps reduce COVID-19 recovery time: study
The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine. Read MoreJun 4, 2020
-
Multinational consortium reports COVID-19 impact on cancer patients
People with cancer sickened by COVID-19 have a crude death rate of 13%, according to the largest series of data released thus far from a multinational perspective. The data on more than 900 patients also revealed cancer-specific factors associated with increased mortality. Read MoreJun 3, 2020
-
Diversity in chemistry professor’s lab creates opportunity, explores clues to Alzheimer’s
Renã Robinson, associate professor of chemistry, has been immersed in science-related activities and classes since she was a child. Today, she is leading a diverse lab of researchers, using chemistry to uncover clues surrounding Alzheimer’s disease. Read MoreJun 3, 2020
-
Vanderbilt University screening tool assesses COVID-19 risk
A virtual self-screening tool developed by Vanderbilt global health experts will help individuals assess their risk of COVID-19 and provide anonymized data to public health researchers and officials studying the spread of the disease. Read MoreJun 1, 2020
-
Artificial intelligence offers a chance to optimize COVID-19 treatment in international partnership
Jonathan Irish joins an international collaboration by deploying artificial intelligence to optimize COVID-19 treatment and vaccine development. Read MoreMay 29, 2020
-
Target trials support drug safety in pregnant patients
A new paper proposes an ethical way to test drug safety during pregnancy by using electronic health data to conduct "virtual" drug trials. Read MoreMay 28, 2020
-
Research probes why COVID-19 seems to spare young children
Lung disease experts at Vanderbilt University Medical Center and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. Read MoreMay 28, 2020
-
New research reveals environmental pollutant in drinking water is more dangerous than previously understood
Nancy Carrasco has found that the environmental pollutant perchlorate, found in drinking water in 49 states, is more dangerous than we knew. Read MoreMay 26, 2020
-
Team to test app for improving HIV care for new mothers in South Africa
Kate Clouse is working with researchers at the University of Cape Town to develop a phone app that will help new mothers with HIV in South Africa stay connected to the healthcare system during the perinatal period. Read MoreMay 22, 2020
-
VUMC research ramps up in COVID-19 transition
As Nashville cautiously begins to emerge from its two-month-long COVID-19 Safer at Home response, so too are the labs and facilities at Vanderbilt University Medical Center. Read MoreMay 21, 2020
-
Team uses imaging to study ways the heart is affected by coronavirus
Researchers are using imaging and diagnostic pathology to examine postmortem hearts donated by victims of COVID-19 to gain a better understanding of how the coronavirus that causes COVID-19 affects the heart. Read MoreMay 21, 2020